Inflexxion, Inc. has appointed Jody Green, PhD as chief scientific officer. She comes with a strong background in the drug safety and opioid abuse space.  

In her new role, she will lead the scientific efforts of Inflexxion in the areas of behavioral health, substance abuse, pain management, epidemiology, opioid risk management, and compliance.  Dr. Green last served as Director of Research Administration at Denver Health/Rocky Mountain & Poison Drug Center. 

“I am delighted to welcome Dr. Green to the Inflexxion team,” said Bruno Lempernesse, chief executive officer at Inflexxion.  “With Dr. Green’s appointment, we are strengthening our Scientific Team as we continue to broaden our service offerings and expertise as thought leaders.”